First Look Analysts Research Calls for Monday, March 13

This report was sent to Briefing.com subscribers earlier today. https://briefing.com

Upgrades:

> Amgen (AMGN) upgraded to Overweight from Equal Weight at Wells Fargo; tgt lowered to $265

> Eli Lilly (LLY) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $375

> JPMorgan Chase (JPM) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $155

> Moderna (MRNA) upgraded to Outperform from Market Perform at TD Cowen; tgt raised to $180

> SAGE Therapeutics (SAGE) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $60

Downgrades:

> Allbirds (BIRD) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $1.50

> British American Tobacco (BTI) downgraded to Neutral from Overweight at JP Morgan

> Comerica (CMA) downgraded to Hold from Buy at Odeon

> Hercules Capital (HTGC) downgraded to Underperform from Mkt Perform at Keefe Bruyette; tgt lowered to $10.50

> KeyCorp (KEY) downgraded to Hold from Buy at Odeon

> Logitech Int’l SA (LOGI) downgraded to Neutral from Outperform at Credit Suisse

> Merck (MRK) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $115

> Wells Fargo (WFC) downgraded to Hold from Buy at Odeon

Others:

> Cabot (CBT) initiated with an Outperform at Credit Suisse; tgt $94

> GE HealthCare (GEHC) initiated with an Outperform at Evercore ISI; tgt $90

Contact [email protected] for any questions or corrections.